Back

Exploring the unmet needs of cardiometabolic risk factors and medicines optimisation among post-myocardial infarction patients with diabetes

4 April 2025 (09:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Poster session (2) Secondary Prevention EAPC Premium Access ESC Preventive Cardiology 2025 European Association of Preventive Cardiology (EAPC)

About the speaker

Photo
Ms Sarah Alasmary

University of Leeds, Leeds (United Kingdom of Great Britain & Northern Ireland)

87 More presentations in this session

Presentation thumbnail
Comparative efficacy and safety of antithrombotic regimens following left atrial appendage occlusion therapy in atrial fibrillation patients: a comprehensive Bayesian network meta-analysis
Doctor V. Lanari (Milan, IT)
Abstract Slides
Presentation thumbnail
Paroxysmal atrial fibrillation prediction score based on 24-hours electrocardiogram-monitoring data
Doctor G. Galati (Milan, IT)
Abstract Slides
Presentation thumbnail
Is excessive epicardial fat volume in asymptomatic young adult subjects with normal calcium score the trigger for abnormal ECGs and arrhythmia?
Doctor A. Sabatini (Florence, IT)
Abstract Slides
Presentation thumbnail
Prevention of readmission in the acute setting for heart failure patients: an adapted protocol of levosimendan infusion in inpatient high-intensity cardiac rehabilitation
Doctor I. Cusmano (Milan, IT)
Abstract Slides
Presentation thumbnail
Enhanced external counterpulsation (EECP) as a strategy for left ventricular and microcirculatory improvement: independent of cardiac intervention
Doctor O. Handayani (Jakarta, ID)
Abstract Slides

Access the full session

Session thumbnail
Poster session (2)

The Event

Event poster

ESC Preventive Cardiology 2025

4 April 2025 09:00 CET
You may be interested in
thumbnail
Congress Presentation
Efficacy and safety of dapagliflozin in non-diabetic patients with anterior wall ST-segment elevation acute myocardial infarction
thumbnail
Congress Presentation
Newly diagnosed diabetes at acute myocardial infarction presentation: higher glycemic burden, more multivessel-disease but similar clinical severity to non-diabetics
thumbnail
Congress Presentation
Cardiovascular benefits of SGLT2i in type 2 diabetes without heart failure: a subgroup analysis

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources